Replies to post #127367 on Biotech Values

[biomaven0]

Note that the imatinib dose for PAH is likely to be 200mg, which is not one of approved dosage strengths for Gleevec.

Well 2x100mg isn't too hard for most patients to manage. :)

I don't think I've ever seen a successful attempt to get brand pricing for a new indication given an approved generic with a compatible dosing form. (Some years back I seem to recall an acne/rosacea drug that used a very low dose of an approved antibiotic (minocycline or doxycycline maybe), but there you couldn't split the pills to get the right dose).

Peter

[rkrw]

Novartis is also planning a new brand name for PAH.